Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership296,073 shares
Latest Disclosed Value $ 15,472,775
Bnp Paribas Arbitrage, Sa ownership in TECH / Bio-Techne Corporation

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 296,073 shares of Bio-Techne Corporation (US:TECH) valued at $15,472,775 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 285,151 shares of Bio-Techne Corporation. This represents a change in shares of 3.83% during the quarter. The current value of the position is $15,055,312 USD.

Bnp Paribas Arbitrage, Sa has a history of taking positions in derivatives of the underlying security (TECH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TECH / Bio-Techne Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Bio-Techne Equity 09073M104 296,073 10,922 3.83 15,473 -7.73 0.0075
2026-02-10 2025-12-31 13F Bio-Techne Equity 09073M104 285,151 34,255 13.65 16,770 20.15 0.0076
2025-11-13 2025-09-30 13F Bio-Techne Equity 09073M104 250,896 -166,664 -39.91 13,957 -35.03 0.0075
2025-08-14 2025-06-30 13F Bio-Techne Equity 09073M104 417,560 58,937 16.43 21,483 2.17 0.0123
2025-05-14 2025-03-31 13F Bio-Techne Equity 09073M104 358,623 76,876 27.29 21,026 3.61 0.0124
2025-02-14 2024-12-31 13F Bio-Techne Equity 09073M104 281,747 107,667 61.85 20,294 45.85 0.0114
2024-11-13 2024-09-30 13F Bio-Techne Equity 09073M104 174,080 -52,235 -23.08 13,914 -14.19 0.0093
2024-08-13 2024-06-30 13F Bio Techne Equity 09073M104 226,315 10,141 4.69 16,215 6.57 0.0132
2024-05-01 2024-03-31 13F Bio-Techne Equity 09073M104 216,174 73,453 51.47 15,216 38.18 0.0134
2024-02-14 2023-12-31 13F/A-2 Bio Techne Equity 09073M104 142,721 36,590 34.48 11,012 52.44 0.0125
2024-02-07 2023-12-31 13F/A-1 Bio Techne Equity 09073M104 142,721 36,590 11,012 0.0016
2024-02-07 2023-12-31 13F Bio Techne Equity 09073M104 142,721 11,012
2023-11-14 2023-09-30 13F Bio-Techne Equity 09073M104 106,131 -10,772 -9.21 7,224 -24.29 0.0093
2023-08-09 2023-06-30 13F Bio-Techne Equity 09073M104 116,903 -24,143 -17.12 9,543 -8.81 0.0119
2023-05-12 2023-03-31 13F BIO TECHNE EQUITY 09073M104 141,046 66,187 88.42 10,464 68.67 0.0147
2023-02-14 2022-12-31 13F Bio Techne Equity 09073M104 74,859 16,002 27.19 6,204 -62.88 0.0095
2022-11-16 2022-09-30 13F/A-1 Bio-Techne Equity 09073M104 58,857 27,989 90.67 16,715 56.21 0.0267
2022-11-15 2022-09-30 13F Bio-Techne Equity 09073M104 58,857 27,989 16,715 0.0040
2022-08-12 2022-06-30 13F Bio Techne Equity 09073M104 30,868 6,890 28.73 10,700 3.05 0.0167
2022-05-18 2022-03-31 13F/A-1 Bio Techne Equity 09073M104 23,978 -6,068 -20.20 10,383 -33.20 0.0140
2022-02-09 2021-12-31 13F BIO TECHNE EQUITY 09073M104 30,046 517 1.75 15,544 8.63 0.0221
2021-11-16 2021-09-30 13F/A-1 BIO TECHNE EQUITY 09073M104 29,529 17,249 140.46 14,309 158.78 0.0203
2021-11-12 2021-09-30 13F BIO TECHNE EQUITY 09073M104 4,401 -7,879 1,090 0.0000
2021-08-10 2021-06-30 13F BIO TECHNE EQUITY 09073M104 12,280 3,247 35.95 5,529 60.31 0.0073
2021-05-07 2021-03-31 13F BIO TECHNE EQUITY 09073M104 9,033 3,121 52.79 3,450 83.75 0.0050
2021-02-10 2020-12-31 13F BIO TECHNE EQUITY 09073M104 5,912 1,511 34.33 1,877 72.20 0.0035
2020-10-30 2020-09-30 13F BIO TECHNE EQUITY 09073M104 4,401 -1,085 -19.78 1,090 -24.72 0.0016
2020-08-06 2020-06-30 13F BIO TECHNE EQUITY 09073M104 5,486 -40,859 -88.16 1,449 -83.52 0.0026
2020-05-13 2020-03-31 13F BIO TECHNE EQUITY 09073M104 46,345 22,407 93.60 8,788 67.24 0.0180
2020-02-12 2019-12-31 13F BIO TECHNE EQUITY 09073M104 23,938 15,452 182.09 5,255 216.51 0.0096
2019-11-07 2019-09-30 13F BIO TECHNE EQUITY 09073M104 8,486 -38,858 -82.08 1,660 -83.18 0.0029
2019-07-30 2019-06-30 13F BIO TECHNE EQUITY 09073M104 47,344 32,989 229.81 9,871 246.32 0.0197
2019-04-25 2019-03-31 13F BIO TECHNE EQUITY 09073M104 14,355 -54,592 -79.18 2,850 -71.44 0.0062
2019-02-12 2018-12-31 13F BIO TECHNE EQUITY 09073M104 68,947 53,611 349.58 9,978 218.79 0.0236
2018-11-07 2018-09-30 13F BIO TECHNE EQUITY 09073M104 15,336 8,108 112.17 3,130 192.80 0.0046
2018-07-25 2018-06-30 13F BIO TECHNE EQUITY 09073M104 7,228 -2,515 -25.81 1,069 -27.33 0.0018
2018-05-11 2018-03-31 13F BIO TECHNE EQUITY 09073M104 9,743 -7,719 -44.20 1,472 -34.97 0.0028
2018-03-05 2017-12-31 13F/A-1 BIO TECHNE EQUITY 09073M104 17,462 -468 -2.61 2,262 4.38 0.0040
2018-02-01 2017-12-31 13F BIO-TECHNE EQUITY 09073M104 17,462 -468 2,262
2017-11-03 2017-09-30 13F BIO TECHNE STOCK 09073M104 17,930 -1,950 -9.81 2,168 -7.19 0.0053
2017-08-03 2017-06-30 13F BIO TECHNE STOCK 09073M104 19,880 5,968 42.90 2,336 65.13 0.0070
2017-05-03 2017-03-31 13F BIO TECHNE STOCK 09073M104 13,912 -2,061 -12.90 1,414 -13.89 0.0037
2017-02-14 2016-12-31 13F BIO TECHNE STOCK 09073M104 15,973 7,220 82.49 1,643 71.40 0.0077
2016-10-05 2016-09-30 13F * BIO TECHNE CORP COM STOCK 09073M104 8,753 -12,281 -58.39 958 -59.61 0.0039
2016-07-06 2016-06-30 13F * BIO TECHNE CORP COM STOCK 09073M104 21,034 13,587 182.45 2,372 237.41 0.0107
2016-04-22 2016-03-31 13F * BIO TECHNE CORP COM STOCK 09073M104 7,447 625 9.16 704 14.68 0.0030
2016-04-19 2015-12-31 13F/A-1 * BIO TECHNE CORP COM STOCK 09073M104 6,822 -1,198 -14.94 614 -17.27 0.0030
2016-02-10 2015-12-31 13F * BIO TECHNE CORP COM STOCK 09073M104 6,822 614
2015-11-13 2015-09-30 13F * BIO TECHNE CORP COM STOCK 09073M104 8,020 303 3.93 742 -2.37 0.0019
2015-08-14 2015-06-30 13F BIO TECHNE CORP COM STOCK 09073M104 7,717 6,295 442.69 760 434.51 0.0021
2015-05-15 2015-03-31 13F * BIO TECHNE CORP COM STOCK 09073M104 1,422 393 38.19 143 49.47 0.0004
2015-03-10 2014-12-31 13F/A-1 * BIO TECHNE CORP COM ADDED STOCK 09073M104 1,029 48 4.89 95 4.40 0.0003
2015-02-11 2014-12-31 13F * BIO TECHNE CORP COM ADDED STOCK 09073M104 1,029 95
2014-11-12 2014-09-30 13F * TECHNE CORP COM STOCK 878377100 981 634 182.71 92 184.38 0.0001
2014-08-14 2014-06-30 13F/A-1 * TECHNE CORP COM STOCK 878377100 347 -1,995 -85.18 32 -84.69 0.0000
2014-08-14 2014-06-30 13F TECHNE CORP COM STOCK 878377100 347 32
2014-05-13 2014-03-31 13F TECHNE STOCK 878377100 2,342 1,734 285.20 209 266.67 0.0002
2014-04-02 2013-12-31 13F/A-1 TECHNE STOCK 878377100 608 608 58 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-07 2023-12-31 13F/A Bio-Techne Option Call 0 0 n/a n/a n/a
2024-02-14 2023-12-31 13F/A Bio-Techne Option Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-07 2023-12-31 13F Bio-Techne Option Call 0 0 n/a n/a n/a
2023-11-14 2023-09-30 13F Bio-Techne Option Call 231 1,572 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.